- Home
- ONC vs FICO Comparison
ONC vs FICO Comparison
Compare ONC & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | FICO |
|---|---|---|
| Founded | 2010 | 1956 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 41.2B |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | ONC | FICO |
|---|---|---|
| Price | $322.79 | $1,797.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $369.50 | ★ $2,050.69 |
| AVG Volume (30 Days) | ★ 332.1K | 175.5K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.78 |
| EPS | 0.58 | ★ 26.54 |
| Revenue | ★ $4,972,687,000.00 | $1,990,869,000.00 |
| Revenue This Year | $36.37 | $20.80 |
| Revenue Next Year | $22.04 | $16.38 |
| P/E Ratio | $553.50 | ★ $67.77 |
| Revenue Growth | ★ 53.47 | 15.91 |
| 52 Week Low | $170.99 | $1,300.00 |
| 52 Week High | $385.22 | $2,400.00 |
Technical Indicators
Market Signals| Indicator | ONC | FICO |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 58.19 |
| Support Level | $325.00 | $1,756.00 |
| Resistance Level | $340.98 | $1,800.69 |
| Average True Range (ATR) | 13.32 | 49.15 |
| MACD | -3.46 | -2.49 |
| Stochastic Oscillator | 16.88 | 71.92 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.